JASPER THERAPEUTICS INC (JSPR:NASDAQ)
$0.4586 -0.0074 (-1.588%)
Analysed JASPER THERAPEUTICS INC (JSPR:NASDAQ) News Sources
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
07-01-2026
yahoo.com
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
08-01-2026
yahoo.com
Jasper Therapeutics reports updated data from briquilimab studies
09-01-2026
yahoo.com
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
24-02-2026
yahoo.com
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab
29-03-2026
yahoo.com
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
30-03-2026
yahoo.com
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7
07-04-2026
yahoo.com
Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
14-05-2026
yahoo.com
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
01-06-2026
yahoo.com
Bears are Losing Control Over Jasper Therapeutics (JSPR), Here's Why It's a 'Buy' Now
03-06-2026
yahoo.com
What is the current price of JASPER THERAPEUTICS INC (JSPR:NASDAQ)?
The current price of JASPER THERAPEUTICS INC (JSPR:NASDAQ) is $0.4586.
JASPER THERAPEUTICS INC (JSPR:NASDAQ) absolute price change since previous trading day?
The absolute price change of JASPER THERAPEUTICS INC (JSPR:NASDAQ) since the previous trading day is $-0.0074.
JASPER THERAPEUTICS INC (JSPR:NASDAQ) percentage price change since previous trading day?
The percentage price change of JASPER THERAPEUTICS INC (JSPR:NASDAQ) since the previous trading day is -1.588%.
What is the most recent average sentiment score for JASPER THERAPEUTICS INC (JSPR:NASDAQ)?
The most recent average sentiment score for JASPER THERAPEUTICS INC (JSPR:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for JASPER THERAPEUTICS INC (JSPR:NASDAQ)?
The most recent sentiment for JASPER THERAPEUTICS INC (JSPR:NASDAQ) is .
SEC-8K** Filing Available For JASPER THERAPEUTICS INC (JSPR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.